Chemicals classified as WDR18 activators tap into intricate molecular processes within cells. Many of these activators function by targeting key biochemical pathways that intersect with the roles of WD repeat proteins, possibly including WDR18. For instance, Okadaic Acid, a known of serine/threonine-specific protein phosphatases, to influence WDR18 by modulating phosphorylation-dependent processes. Such post-translational modifications play critical roles in the function and stability of numerous proteins, and their alteration can indirectly modulate proteins like WDR18. Similarly, calcium dynamics, fundamental to various cellular processes, can be modulated using BAPTA-AM, an intracellular calcium chelator. The fluctuation of intracellular calcium levels can ripple across many pathways, affecting proteins, including those from the WD repeat family. In another dimension, the analog 8-Br-cAMP, which can elevate cAMP levels and activate PKA, provides a perspective into how cAMP-mediated processes might modulate the function or stability of WDR18. As cAMP-dependent pathways can intersect with many proteins, there's a possibility that WDR18, being part of the WD repeat family, gets affected by such changes.
G-proteins and their cascades are pivotal to a vast array of cellular events. YM-254890, a specific of the Gq protein, helps elucidate how Gq-mediated pathways might intersect with WDR18's function. Tyrosine kinases, integral to numerous cellular signals, can be targeted using Genistein. By influencing tyrosine kinase pathways, this compound might offer insights into their relationship with WDR18. On the flip side, PKC, another vital kinase in signaling pathways, can be activated using Phorbol 12-Myristate 13-Acetate (PMA).
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Serine/threonine-specific protein phosphatase inhibitor. Can indirectly modulate WDR18 by affecting phosphorylation-dependent processes that could involve WD repeat proteins. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Intracellular calcium chelator. As calcium dynamics can impact many WD repeat protein-involved processes, BAPTA-AM can indirectly affect WDR18's activity by modulating intracellular calcium levels. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
cAMP analog that activates PKA. By modulating cAMP-dependent pathways, which can involve WD repeat proteins, 8-Br-cAMP can indirectly influence the activity or stability of WDR18. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $500.00 | ||
Gq protein inhibitor. By inhibiting Gq-mediated signaling, YM-254890 can modulate processes where WD repeat proteins, including WDR18, may play a role. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor. By targeting tyrosine kinase-mediated cascades, Genistein has the potential to indirectly influence WDR18 if its function intertwines with these pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PKC activator. WDR18, if part of PKC-dependent processes, can be modulated by PMA due to its potent activation of PKC. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
PDE4 inhibitor, increasing cAMP levels. An elevated cAMP environment can influence pathways in which WD repeat proteins operate, potentially modulating WDR18. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $134.00 $502.00 | 7 | |
CDC42 inhibitor. Given that the CDC42 pathway might overlap with WD repeat protein functions, ML141 offers a window to potentially influence WDR18. | ||||||
8-pCPT-2′-O-Me-cAMP | 634207-53-7 | sc-257020 | 1 mg | $300.00 | 5 | |
Epac activator, separate from PKA. The Epac pathway can intersect with functions of WD repeat proteins, offering a means to modulate WDR18 indirectly. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
Non-muscle myosin II inhibitor. Given that non-muscle myosin II can be part of processes involving WD repeat proteins, Blebbistatin can potentially affect WDR18 indirectly. | ||||||